Core Laboratories (CLB) Misses Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts CLB Hot Sheet
Price: $11.57 -0.69%
EPS Growth %: +36.4%
Financial Fact:
Net income attributable to Core Laboratories N.V.: 16.73M
Today's EPS Names:
CRMT, FOMI, FLES, More
EPS Growth %: +36.4%
Financial Fact:
Net income attributable to Core Laboratories N.V.: 16.73M
Today's EPS Names:
CRMT, FOMI, FLES, More
Join SI Premium – FREE
Core Laboratories (NYSE: CLB) reported Q2 EPS of $0.18, $0.02 worse than the analyst estimate of $0.20. Revenue for the quarter came in at $118.7 million versus the consensus estimate of $119.38 million.
GUIDANCE:
Core Laboratories sees Q3 2021 EPS of $0.19-$0.21, versus the consensus of $0.23.
For earnings history and earnings-related data on Core Laboratories (CLB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump discloses over $1.4 billion in crypto income in 2025 filing
- Whirlpool to close Mexico plant, expects $165M restructuring cost
- General Mills (GIS) Tops Q4 EPS by 14c, Beats on Revenue; Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
